Role of the selective cyclo-oxygenase-2 (COX-2) inhibitors in children

@inproceedings{Turner2004RoleOT,
  title={Role of the selective cyclo-oxygenase-2 (COX-2) inhibitors in children},
  author={Sean W. D. Turner and V. James Ford},
  year={2004}
}
Correspondence to: Mr Sean Turner, Clinical Services, Princess Margaret Hospital, Roberts Road, Perth, Western Australia 6008, Australia; sean.turner@health. wa.gov.au _________________________ T here has been a great deal written about the use of selective cyclo-oxygenase-2 (COX-2) inhibitors in the adult population. Yet despite this there is still controversy over their place in treatment and in the interpretation of evidence from the major clinical trials. In the UK the National Institute… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Adverse Drug Reactions Bulletin 2004;23:10–11

D Mukherjee, SE Nissen, EJ. Topol
2004

Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea.

Journal of pediatric and adolescent gynecology • 2004

Parecoxib — one shot only

D Mukherjee, SE Nissen, EJ Topol
Australian Adverse Drug Reactions Bulletin • 2004

Pediatr Adolesc Gynecol 2004;17:75–9

J dysmenorrhoea
2004

Pharmacokinetics of rofecoxib in children [ abstract ]

JP Boni, JM Korth-Bradley, P Martin
Clin Pharmacol Ther • 2004

abstract]. Pain 2004;5:S84

JE Munro, KJ Murray
2004

control after tonsillectomy in children [ abstract ]

JE Munro, KJ Murray
2004

Acute neuropsychiatric events with celecoxib and rofecoxib

F Schneider, F Meziani, C Chartier
Australian Adverse Drug Reactions Bulletin • 2003